http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1117117-T1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5176dd638294e47a46f6b25df6ce35f6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate | 2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c17666036db8e0fd8291345b502f18d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_115ea6567b30b59de263ac8bca0e4482 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7efe9f470e077e47fbfe8e6ed634ab44 |
| publicationDate | 2017-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CY-1117117-T1 |
| titleOfInvention | ROSTAFOUROXIN FOR PHARMACOGONIDATIVE THERAPEUTIC TREATMENT |
| abstract | Methods and systems are provided herein which are based on the effects of genetic variants on the biological activities associated with rostafuroxin in a subject. In particular, compositions, methods and systems are described herein based on a defined influence on a single response to rostafuroxin of one or more polymorphisms in a transgenic or endogenous region of a gene selected from the group consisting of KCNS3, THSD70A, FSD7A, F38, HLA-G, and TTC29 and / or a genetic variant in the parental attachment disorder disorder. |
| priorityDate | 2009-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.